<?xml version='1.0' encoding='UTF-8' standalone='no'?>
<rdf:RDF xmlns:dc="http://dublincore.org/specifications/dublin-core/dcmi-terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:bqbiol="http://biomodels.net/biology-qualifiers/" xmlns:collex="http://www.collex.org/schema#" xmlns:bqmodel="http://biomodels.net/model-qualifiers/" xmlns:scoro="http://purl.org/spar/scoro/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <dc:title>Kirschner, Panetta, 1998</dc:title>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <prism:keyword>T cell</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <prism:keyword>immunology</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <prism:keyword>signal transduction</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <prism:keyword>cytokine</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <prism:keyword>pharmacology</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <prism:keyword>tumour</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <prism:keyword>t cell</prism:keyword>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <dc:description>Model Status

            This model has been recoded using the nondimensionalized equations. This was suggested by the author to help with solving the problem, due to its very stiff nature. Some but not all output from the paper can be reproduced by this model. Values of s1 and s2 have been set to zero to represent a non-treatment situation. A value of 0.02 has been given to the variable c, which defines the antigenicity of the tumour, to represent the middle of the range given for this parameter. The model may be re-parameterised to give other relevant outputs, for example, if s1 is greater than 0 while s2 equals 0, the model can simulate adoptive cellular immunotherapy.  The model will not run in COR due to time being defined as dimensionless.
          
Model Structure

		ABSTRACT: A number of lines of evidence suggest that immunotherapy with the cytokine interleukin-2 (IL-2) may boost the immune system to fight tumors. CD4+ T cells, the cells that orchestrate the immune response, use these cytokines as signaling mechanisms for immune-response stimulation as well as lymphocyte stimulation, growth, and differentiation. Because tumor cells begin as 'self', the immune system may not respond in an effective way to eradicate them. Adoptive cellular immunotherapy can potentially restore or enhance these effects. We illustrate through mathematical modeling the dynamics between tumor cells, immune-effector cells, and IL-2. These efforts are able to explain both short tumor oscillations in tumor sizes as well as long-term tumor relapse. We then explore the effects of adoptive cellular immunotherapy on the model and describe under what circumstances the tumor can be eliminated.     


The original paper reference is cited below:


Modeling immunotherapy of the tumor-immune interaction, Denise Kirschner and John Carl Panetta, 1998,
            Journal of Mathematical Biology, 37, 235-252.  PubMed ID: 9785481
</dc:description>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <dc:identifier rdf:resource="None">None</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <rdfs:label>PMR workspace</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <dc:source rdf:resource="local:00001">local:00001</dc:source>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <rdfs:label>Denise Kirschner</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00002">
    <foaf:name>Denise Kirschner</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <dc:creator rdf:resource="local:00002">local:00002</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00003">
    <rdfs:label>John Carl Panetta</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="local:00003">
    <foaf:name>John Carl Panetta</foaf:name>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <dc:creator rdf:resource="local:00003">local:00003</dc:creator>
  </rdf:Description>
  <rdf:Description rdf:about="local:00004">
    <dc:identifier rdf:resource="https://creativecommons.org/licenses/by/3.0/">https://creativecommons.org/licenses/by/3.0/</dc:identifier>
  </rdf:Description>
  <rdf:Description rdf:about="local:00004">
    <rdfs:label>ccby</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://omex-library.org/b28e4ff036c76cd0581efe5c3e4f796e.omex">
    <dc:license rdf:resource="local:00004">local:00004</dc:license>
  </rdf:Description>
</rdf:RDF>
